---
title: "Kazia Therapeutics (KZIA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KZIA.US/norm.md"
symbol: "KZIA.US"
name: "Kazia Therapeutics"
parent: "https://longbridge.com/en/quote/KZIA.US.md"
datetime: "2026-06-13T16:31:01.406Z"
locales:
  - [en](https://longbridge.com/en/quote/KZIA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KZIA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KZIA.US/norm.md)
---

# Kazia Therapeutics (KZIA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.35 | -1.32 | -2.49 | -2.40 | -3.82 |
| ROE | -54.03% | -131.56% | 246.91% | 338.54% | 549.11% |
| Revenue | 30769.90 | 30235.51 | 589426.46 | 567933.48 | 6933.13 |
| Net income | -4.20M | -4.13M | -3.34M | -3.22M | -3.25M |
| Operating income | -4.51M | -4.43M | -1.58M | -1.52M | -2.91M |
| Gross margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Net margin | -13655.59% | -13655.59% | -567.23% | -567.23% | -46899.10% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 47.61M | 46.78M | 3.95M | 3.81M | 11.14M |
| Leverage | 1.53 | 1.53 | -0.7302 | -0.7302 | -4.70 |
| BVPS | 2.74 | 2.70 | -3.35 | -3.22 | -2.45 |
| Turnover | 0.0427 | 0.0419 | 0.1323 | 0.1567 | 0.1184 |
| Cash & STI | 46.50M | 45.69M | 2.84M | 2.73M | 1.91M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -46.44M | -45.63M | -2.58M | -2.48M | -1.82M |

## Cash Flow Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.19M | -3.14M | -1.58M | -1.53M | -2.62M |
| Investing CF | - | - | - | - | - |
| Financing CF | 25.21M | 24.78M | 2.04M | 1.96M | 3.03M |
| Free CF | -1.26M | 5.78M | -927341.12 | -2.76M | -1.39M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |